Duncan Williams Asset Management, LLC
Source: SEC Form 13F · as of Mar 2026Duncan Williams Asset Management, LLC holds 5 biotech & pharma companies tracked by BioSniper, totaling $2.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
5
Total value held
$2.5M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Apellis Pharmaceuticals, Inc. (APLS)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| APLSApellis Pharmaceuticals, Inc. | 17,005 | $684K |
| PRTAPROTHENA CORP PUBLIC LTD CO | 70,281 | $683K |
| ZYMEZymeworks Inc. | 22,095 | $553K |
| ANABANAPTYSBIO, INC | 6,525 | $362K |
| TVRDTvardi Therapeutics, Inc. | 63,241 | $201K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.